Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

193.83 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
99 100 Next >
U.S. Labor Market Shows Mixed Signals: Unemployment Claims Tick Up, Job Growth Slows
Recent economic data from the United States has presented a nuanced picture of the nation's labor market, with a slight uptick in unemployment benefit applications alongside a significantly... 
Via MarketMinute
Topics Bonds Economy
Political Tremors Rattle Markets: The Profound Impact of U.S. Elections and Tariff Shocks
The intricate dance between political shifts and financial markets has once again taken center stage, demonstrating the profound influence of electoral outcomes and subsequent policy decisions on... 
Via MarketMinute
Topics Economy Government Stocks
U.S. Economy Navigates Choppy Waters: Weak Payrolls, Labor Slowdown, and Persistent Inflation Reshape Market Outlook
The United States economy is currently grappling with a complex and often contradictory narrative, marked by recent weak payrolls data, a discernible slowdown in the labor market, and persistent... 
Via MarketMinute
Topics Earnings Economy World Trade
Stagflation Fears Resurface: Economic Data Signals Market Caution
A troubling confluence of recent economic data points has sent a shiver through financial markets, reigniting fears of "stagflation"—a dreaded economic scenario characterized by stagnant growth, high... 
Via MarketMinute
Topics Bonds Economy Government
Stagflation Specter Haunts Markets as Economic Data Disappoints
The global financial markets are grappling with a growing sense of unease as recent economic data points to a troubling confluence of high inflation and sluggish growth, rekindling fears of... 
Via MarketMinute
Topics Economy Stocks World Trade
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
Eli Lilly and Amgen are suing HHS over 340B certifications, claiming ineligible clinics cost them millions in lost revenue. 
Via Benzinga
Topics Lawsuit
Wall Street Giants Warn of Impending Stock Market Pullback: Is a Correction on the Horizon?
Major Wall Street firms, including Morgan Stanley (NYSE: MS), Deutsche Bank AG (NYSE: DB), and Evercore ISI (NYSE: EVR), have issued cautionary advisories to their clients, signaling a potential stock... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
Beyond Jobs: Key Economic Indicators Investors Are Watching for Market Health Clues
While monthly jobs reports often grab headlines, savvy investors are increasingly looking beyond employment figures to a broader array of economic indicators for a more nuanced understanding of market... 
Via MarketMinute
Topics Economy Supply Chain World Trade
Are Stocks Overheating? Analysts Debate Market Valuations Amidst Record Highs
Concerns are mounting among financial analysts that the U.S. stock market may be entering an "overheated" phase, with equity valuations reaching levels that some deem unsustainable. This apprehension... 
Via MarketMinute
Topics Bonds Economy
Johnson & Johnson (NYSE:JNJ) Stands Out as a Top Dividend Stock for Reliable Income Investors
Johnson & Johnson (JNJ) is a top dividend stock with a 3.16% yield, consistent growth, and strong profitability, making it ideal for income investors seeking stability. 
Via Chartmill
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
In a notable shift, shares of Pfizer (NYSE: PFE) have recently edged higher, reflecting a burgeoning strength within the broader health sector. This uptick signals a renewed investor confidence in the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
From AI To Emerging Markets: How 6 Pros Would Allocate $10K In Today's Market
 
Via Benzinga
Topics Artificial Intelligence
The 3 Things That Matter for Johnson & Johnson Now
Can the stock still deliver the same kinds of returns it has over the past few decades? 
Via The Motley Fool
Topics Bankruptcy Intellectual Property Lawsuit
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
 
Via Benzinga
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Microsoft, Meta Stocks Add $440 Billion In A Day—Nearly Matching Netflix's Entire $503 Billion Market Cap
Microsoft and Meta Platforms added over $400 billion in market capitalization after reporting robust earnings results on Wednesday. 
Via Benzinga
Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, with more data expected. 
Via Benzinga
Drug Prices To Get 'More Expensive' Under Trump's EU Trade Deal As Pharma Faces Billions In Added Costs: Report
The pharmaceutical industry could face a significant financial hit due to the new trade deal between the U.S. and the European Union (EU), potentially leading to increased drug prices and restricted... 
Via Benzinga
Topics Government
2 Unstoppable Dow Dividend Stocks to Buy and Hold Forever
These top Dow dividend stocks have long dividend growth streaks. 
Via The Motley Fool
Topics Bonds Stocks
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever
If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering yields of up to 3.9%. 
Via The Motley Fool
Topics Lawsuit
These 3 Dow Stocks Are Set to Soar in 2025 and Beyond
Plan now for a rotation away from riskier and volatile technology growth stocks and toward blue chips with more promise and predictability. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills
Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants. 
Via Benzinga
Topics Artificial Intelligence ETFs
3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs
US President Trump imposed 200% tariff on pharmaceuticals affecting US drug prices and supply chain, but analysts say it may not happen soon. 
Via Benzinga
Topics Economy Government World Trade
AI Stocks and Options Selling: Is It Worth the Risk?
Artificial intelligence (AI) has become one of the most exciting and volatile sectors in the stock market. As companies like (NASDAQ:NVDA), (NASDAQ:PLTR), and (NASDAQ:TSLA) drive innovation in... 
Via MarketMinute
Topics Artificial Intelligence
Cash-Secured Puts: How to Get Paid to Buy Stocks at a Discount
In a market where volatility creates both fear and opportunity, income-focused investors are increasingly turning to a lesser-known but powerful strategy: selling cash-secured puts. This options... 
Via MarketMinute
Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
From Johnson & Johnson
Via Business Wire
4 Major Stocks Raise 2025 Guidance, Analyst Targets Rise
With solid Q2 results and 2025 guidance increases, Wall Street is upgrading these four stocks. Analysts now see palpable upside in one streaming stalwart. 
Via MarketBeat
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.
Via The Motley Fool
Topics Lawsuit Supply Chain
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.